Q3 2025 Recap: Dermatology News and Updates

As Q3 draws to a close, the HCPLive team reviews pivotal updates across the field of dermatology, with new findings advancing the treatment landscape in psoriasis, atopic dermatitis, alopecia areata, and hidradenitis suppurativa (HS) having been released in this period. This quarter saw encouraging data from research into topical and systemic therapies alike, including recent safety findings on roflumilast cream 0.05% in infants and toddlers with atopic dermatitis, promising biomarker-driven outcomes seen in phase 2b trials on temtokibart, and more.